Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
WEAK demand for its shares has forced drug development firm Cennerv Pharmaceuticals to withdraw its application for an initial public offering (IPO), the company said last week.
The Singapore-based firm had lodged a draft prospectus for a listing on the Catalist board of...